Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/20/24 16:39 | 11/18/24 | KNSA | Health | Drug | Pharmaceutical Preparations | Tessari Eben | X0 | O | COO | 5 | S.d | -1,749 | 24.92 | 0 | -70 | 123 | D | |||||||||||||||
11/8/24 16:34 | 11/6/24 | KNSA | Health | Drug | Pharmaceutical Preparations | Patel Sanj K | X0 | DO | CB,CEO | 4 | S.dm | -7,309 | 23.65 | 0 | -309 | 227 | D | |||||||||||||||
9/4/24 20:52 | 9/3/24 | KNSA | Health | Drug | Pharmaceutical Preparations | Paolini John F. | X0 | O | CHIEF ME | 7 | S.d | -3,855 | 22.72 | 0 | -170 | 52 | D | |||||||||||||||
9/4/24 20:42 | 9/3/24 | KNSA | Health | Drug | Pharmaceutical Preparations | Moat Ross | X0 | O | CHIEF CO | 1 | S.d | -1,789 | 26.12 | 0 | -69 | 22 | D | |||||||||||||||
7/25/24 16:32 | 7/23/24 | KNSA | Health | Drug | Pharmaceutical Preparations | Ragosa Mark | X0 | O | CFO | 2 | S.d | -841 | 23.20 | 0 | -36 | 19 | D | |||||||||||||||
3/1/24 18:26 | 2/28/24 | KNSA | Health | Drug | Pharmaceutical Preparations | Megna Michael R | D0 | O | CHIEF AC | 3 | S.dm | -817 | 20.03 | 0 | -41 | 18 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |